181 related articles for article (PubMed ID: 33923169)
1. Tubulin Inhibitors: A Chemoinformatic Analysis Using Cell-Based Data.
López-López E; Cerda-García-Rojas CM; Medina-Franco JL
Molecules; 2021 Apr; 26(9):. PubMed ID: 33923169
[TBL] [Abstract][Full Text] [Related]
2. Consensus Virtual Screening Protocol Towards the Identification of Small Molecules Interacting with the Colchicine Binding Site of the Tubulin-microtubule System.
López-López E; Cerda-García-Rojas CM; Medina-Franco JL
Mol Inform; 2023 Jan; 42(1):e2200166. PubMed ID: 36175374
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
Tripathi S; Srivastava G; Sharma A
Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Cancer Cell Growth Inhibition Evaluation of New Aminoquinone Hybrid Molecules.
Defant A; Mancini I
Molecules; 2019 Jun; 24(12):. PubMed ID: 31197105
[TBL] [Abstract][Full Text] [Related]
5. Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018).
Haider K; Rahaman S; Yar MS; Kamal A
Expert Opin Ther Pat; 2019 Aug; 29(8):623-641. PubMed ID: 31353978
[No Abstract] [Full Text] [Related]
6. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
Coluccia A; Sabbadin D; Brancale A
Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting of tumorigenic cancer cell lines by microtubule inhibitors.
Abdullah NM; Rosania GR; Shedden K
PLoS One; 2009; 4(2):e4470. PubMed ID: 19214225
[TBL] [Abstract][Full Text] [Related]
8. Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics.
Stec-Martyna E; Ponassi M; Miele M; Parodi S; Felli L; Rosano C
Curr Cancer Drug Targets; 2012 Jul; 12(6):658-66. PubMed ID: 22385515
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel tubulin inhibitors targeting taxanes site by virtual screening, molecular dynamic simulation, and biological evaluation.
Zhang H; Mao J; Yang YL; Liu CT; Shen C; Zhang HR; Xie HZ; Ding L
J Cell Biochem; 2021 Nov; 122(11):1609-1624. PubMed ID: 34237164
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
Zhu H; Li W; Shuai W; Liu Y; Yang L; Tan Y; Zheng T; Yao H; Xu J; Zhu Z; Yang DH; Chen ZS; Xu S
Eur J Med Chem; 2021 Apr; 216():113316. PubMed ID: 33676300
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening.
Federico LB; Silva GM; de Fraga Dias A; Figueiró F; Battastini AMO; Dos Santos CBR; Costa LT; Rosa JMC; de Paula da Silva CHT
Int J Biol Macromol; 2020 Dec; 165(Pt B):3040-3050. PubMed ID: 33736292
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Diarylamide
Liu X; Pang XJ; Liu Y; Liu WB; Li YR; Yu GX; Zhang YB; Song J; Zhang SY
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279387
[TBL] [Abstract][Full Text] [Related]
13. Estradiol dimer inhibits tubulin polymerization and microtubule dynamics.
Jurášek M; Černohorská M; Řehulka J; Spiwok V; Sulimenko T; Dráberová E; Darmostuk M; Gurská S; Frydrych I; Buriánová R; Ruml T; Hajdúch M; Bartůněk P; Dráber P; Džubák P; Drašar PB; Sedlák D
J Steroid Biochem Mol Biol; 2018 Oct; 183():68-79. PubMed ID: 29803726
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel and potent small-molecule inhibitors of tubulin with antitumor activities by virtual screening and biological evaluations.
Liu G; Jiao Y; Huang C; Chang P
J Comput Aided Mol Des; 2019 Jul; 33(7):659-664. PubMed ID: 31165955
[TBL] [Abstract][Full Text] [Related]
15. QSAR and 3D-QSAR models in the field of tubulin inhibitors as anticancer agents.
Marzaro G; Chilin A
Curr Top Med Chem; 2014; 14(20):2253-62. PubMed ID: 25434357
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors.
Xu Q; Bao K; Sun M; Xu J; Wang Y; Tian H; Zuo D; Guan Q; Wu Y; Zhang W
Sci Rep; 2017 Sep; 7(1):11997. PubMed ID: 28931885
[TBL] [Abstract][Full Text] [Related]
17. Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitors.
Romagnoli R; Baraldi PG; Carrion MD; Cruz-Lopez O; Tolomeo M; Grimaudo S; Di Cristina A; Pipitone MR; Balzarini J; Brancale A; Hamel E
Bioorg Med Chem; 2010 Jul; 18(14):5114-22. PubMed ID: 20579891
[TBL] [Abstract][Full Text] [Related]
18. Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking.
Niu MM; Qin JY; Tian CP; Yan XF; Dong FG; Cheng ZQ; Fida G; Yang M; Chen HY; Gu YQ
Acta Pharmacol Sin; 2014 Jul; 35(7):967-79. PubMed ID: 24909516
[TBL] [Abstract][Full Text] [Related]
19. Novel Combretastatin-2-aminoimidazole Analogues as Potent Tubulin Assembly Inhibitors: Exploration of Unique Pharmacophoric Impact of Bridging Skeleton and Aryl Moiety.
Chaudhary V; Venghateri JB; Dhaked HP; Bhoyar AS; Guchhait SK; Panda D
J Med Chem; 2016 Apr; 59(7):3439-51. PubMed ID: 26938120
[TBL] [Abstract][Full Text] [Related]
20. PPAR-gamma inhibitors as novel tubulin-targeting agents.
Schaefer KL
Expert Opin Investig Drugs; 2007 Jul; 16(7):923-6. PubMed ID: 17594179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
